Please login to the form below
SO Patient
This page shows the latest SO Patient news and features for those working in and with pharma, biotech and healthcare.
Roche’s Actemra fails in late-stage severe COVID-19 study
The theory behind testing Actemra in this patient setting is based on the idea that its anti-inflammatory properties could counteract the overactive inflammatory responses observed in the lungs of critically ... Although this class of drug has failed in
Latest news
-
AZ and Novartis ‘most exposed’ to Senate pricing proposals
The thrust of the Part D reforms is to close the so-called ‘donut hole’ or patient coverage gap, which starts when costs rose above the plan’s initial coverage limit ( ... $3, 820 at present) and ends when a patient pays $5, 100 out of pocket.
-
Rivals rise as safety issue mars Pfizer’s DMD gene therapy trial
In three of the children, nausea/vomiting could be controlled with oral anti-emetic drugs, but in one case the side effects were so bad the patient had to be hospitalised
-
$450m diagnostics sale will fuel more Syncona biotech funding
Allis added: “We are so proud of our exceptional, patient-focused team for building a successful radiopharmaceuticals business in only five years.
-
Biogen trumpets safety data for Tecfidera follow-up
The efficacy data aside, for Biogen the emphasis is on the safety data with diroximel fumarate as it attempts to position it as a more patient-friendly alternative to Tecfidera, and ... so encourage patients to switch to the new drug if approved as well
-
NICE wants to stop saying ‘no’ – but needs pharma’s co-operation
I think you [the industry] and organisations like NICE have a responsibility to foster a relationship that generates confidence among patient groups so that they believe that this isn't just ... This includes cell and gene therapies such as Novartis’
More from news
Approximately 1 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
Rise of the patient influencer
So what is a patient influencer? They are patients themselves, who use social media to share the highs and lows of managing their condition on a day-to-day basis. ... Engagement and conversation – patient influencers and their audiences are passionate
-
New truths and realities in these strange times
So, what is the current PoTS patient reality in the COVID-19 world? ... Most of us want to put patient perspectives at the heart of industry activities across the life cycle of a product.
-
Biopharma and orphan drugs
Simply finding participants for clinical trials, for example, is harder if patient numbers are limited. ... So-called ‘genomic signatures’ – genomic markets that can aid in patient stratification – are one example.
-
Mapping the patient journey and minding the gap
The world, he said, had changed. “It’s changed because various patient groups have insisted that it change, and rightly so. ... So how do you do it? Here are six steps to establishing an effective and enduring culture of patient-centricity – and a
-
Women Leaders in UK Healthcare: Liz Henderson
It’s an exciting industry to work in – I love seeing how science is translated into patient benefit and it is so rewarding to work with inspirational people who can turn ... He’s at a great age, with so many questions so life is never boring!
More from intelligence
Approximately 0 fully matching, plus 51 partially matching documents found.
Latest appointments
-
New faces at Synergy Vision, Makara Health and JPA Health
I’m passionate about delivering projects that challenge the status quo and improve patient outcomes, so this is an incredibly exciting time to be at the forefront of medical communications with ... regional health communications campaigns. In her new
-
Ferring appoints executive VP and chief medical officer
Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this ... is perfectly aligned with our
-
Sanofi appoints ‘chief patient officer’
The company explained that Dr Beal will be tasked with elevating the 'perspective of the patient within Sanofi so the company's future healthcare offerings can better incorporate the unique priorities ... the patient perspective advances our approach to
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Site-related factors that can impact patient recruitment
Have you trained the study site staff so that they fully understand the protocol and the target patient population? ... It is likely that healthcare professionals working at study sites are already overworked, so outsourcing patient recruitment
-
Patient-related factors that can impact patient recruitment
If you’ve mapped the patient journey through recruitment stages, make sure you continue to do so throughout the duration of the clinical trial to improve retention, too. ... So there you have it; a selection of patient related factors that can impact
-
Protocol-related issues that can impact patient recruitment
But what steps can the industry take to try to improve patient recruitment? ... So, by gaining insights from your patient population, you can start to ask important questions regarding clinic visits: can they easily get to the clinic?
-
Improving patient retention with the use of patient portals
So, let’s take a closer look into five benefits of a patient portal. ... So, the evidence speaks for itself – patient portals offer improved engagement, which ultimately improves retention in your clinical study.
-
Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment. ... And one way this can be changed is by being more patient centric.
More from PMHub
Approximately 0 fully matching, plus 57 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- 20 for 2020 – Five pharma companies to watch
- Leadership change within Bedrock Group
- Moderna inks R&D agreements with Vertex and Chiesi
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
